Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer

被引：41

作者：

Traina, Tiffany A.

Norton, Larry

Drucker, Karen

Singh, Buvanesh

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA

来源：

ONCOLOGIST | 2006年 / 11卷 / 10期

关键词：

D O I：

10.1634/theoncologist.11-10-1070

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：1070 / 1071

页数：2

共 12 条

[1]

Bevacizumab-induced nasal septum perforation [J].

Fakih, Marwan G. ;

Lombardo, Jeffrey C. .

ONCOLOGIST, 2006, 11 (01) :85-86

[2]

*GEN INC, 2004, AV BEV INTR US PACK

[3]

GIANTONIO BJ, 2005, J CLIN ONCOL S, V23, pA169

[4]

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[5]

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer [J].

Johnson, DH ;

Fehrenbacher, L ;

Novotny, WF ;

Herbst, RS ;

Nemunaitis, JJ ;

Jablons, DM ;

Langer, CJ ;

DeVore, RF ;

Gaudreault, J ;

Damico, LA ;

Holmgren, E ;

Kabbinavar, F .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2184-2191

[6]

Miller K., 2005, 28 ANN SAN ANT BREAS

[7]

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer [J].

Miller, KD ;

Chap, LI ;

Holmes, FA ;

Cobleigh, MA ;

Marcom, PK ;

Fehrenbacher, L ;

Dickler, M ;

Overmoyer, BA ;

Reimann, JD ;

Sing, AP ;

Langmuir, V ;

Rugo, HS .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :792-799

[8]

Öberg D, 2003, RHINOLOGY, V41, P72

[9]

Rosen Lee S, 2002, Cancer Control, V9, P36

[10]

Sandler AB, 2004, J CLIN ONCOL, V22, p127S

← 1 2 →